Development and validation of UHPLC–MS/MS methods for the quantification of colistin in plasma and dried plasma spots

[Display omitted] •A new method to quantify colistin A and B in dried plasma spots (DPS) is reported.•The method was compared to a standard method to quantify colistin in plasma.•Colistin on DPS was found to be stable at least for one week at 20–25°C.•A good correlation was observed among the two ch...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical and biomedical analysis Vol. 129; pp. 551 - 557
Main Authors Cangemi, Giuliana, Barco, Sebastiano, Castagnola, Elio, Tripodi, Gino, Favata, Fabio, D’Avolio, Antonio
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 10.09.2016
Subjects
Online AccessGet full text
ISSN0731-7085
1873-264X
1873-264X
DOI10.1016/j.jpba.2016.08.002

Cover

Abstract [Display omitted] •A new method to quantify colistin A and B in dried plasma spots (DPS) is reported.•The method was compared to a standard method to quantify colistin in plasma.•Colistin on DPS was found to be stable at least for one week at 20–25°C.•A good correlation was observed among the two chromatographic methods.•DPS is useful to store and ship samples in a cheaper and safer manner. Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients’ population. Nevertheless, therapeutic drug monitoring of colistin is still limited probably for the low number of laboratories which perform this analysis and for high shipment costs. We developed and validated new UHPLC–MS/MS methods to quantify colistin in plasma and in dried plasma spots (DPS) collected on dried sample spots devices (DSSD). Colistin A, Colistin B and polimixin B, used as internal standard, were detected using multiple reaction monitoring (MRM) of the following specific transitions: 585.5→534.9; 576, 578.5→527.9; 568.9 and 602.5→100.9, 551.9, 592.8, respectively. Colistin A and B were extracted from plasma using protein precipitation and from DSSD using an extraction basic solution. Both methods were validated, and the mean intra and inter-day accuracies and precisions were in accordance with FDA and EMA guidelines. Colistin in DPS was found to be stable for at least one week at room temperature (20–25°C). A statistically significant linear correlation was found between colistin extracted from plasma and from DPS [r2 0.9864 (P<0.0001, 95% CI 0.9699–0.9939) for colistin A and 0.9695 (P<0.0001, 95% CI 0.9310–0.9866) for colistin B, respectively]. DPS on DSSD represents a safe and cheap strategy to store and ship at room temperature plasma samples. Thus, it is suited for pharmacokinetic studies and therapeutic drug monitoring of colistin.
AbstractList [Display omitted] •A new method to quantify colistin A and B in dried plasma spots (DPS) is reported.•The method was compared to a standard method to quantify colistin in plasma.•Colistin on DPS was found to be stable at least for one week at 20–25°C.•A good correlation was observed among the two chromatographic methods.•DPS is useful to store and ship samples in a cheaper and safer manner. Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients’ population. Nevertheless, therapeutic drug monitoring of colistin is still limited probably for the low number of laboratories which perform this analysis and for high shipment costs. We developed and validated new UHPLC–MS/MS methods to quantify colistin in plasma and in dried plasma spots (DPS) collected on dried sample spots devices (DSSD). Colistin A, Colistin B and polimixin B, used as internal standard, were detected using multiple reaction monitoring (MRM) of the following specific transitions: 585.5→534.9; 576, 578.5→527.9; 568.9 and 602.5→100.9, 551.9, 592.8, respectively. Colistin A and B were extracted from plasma using protein precipitation and from DSSD using an extraction basic solution. Both methods were validated, and the mean intra and inter-day accuracies and precisions were in accordance with FDA and EMA guidelines. Colistin in DPS was found to be stable for at least one week at room temperature (20–25°C). A statistically significant linear correlation was found between colistin extracted from plasma and from DPS [r2 0.9864 (P<0.0001, 95% CI 0.9699–0.9939) for colistin A and 0.9695 (P<0.0001, 95% CI 0.9310–0.9866) for colistin B, respectively]. DPS on DSSD represents a safe and cheap strategy to store and ship at room temperature plasma samples. Thus, it is suited for pharmacokinetic studies and therapeutic drug monitoring of colistin.
Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients' population. Nevertheless, therapeutic drug monitoring of colistin is still limited probably for the low number of laboratories which perform this analysis and for high shipment costs. We developed and validated new UHPLC-MS/MS methods to quantify colistin in plasma and in dried plasma spots (DPS) collected on dried sample spots devices (DSSD). Colistin A, Colistin B and polimixin B, used as internal standard, were detected using multiple reaction monitoring (MRM) of the following specific transitions: 585.5→534.9; 576, 578.5→527.9; 568.9 and 602.5→100.9, 551.9, 592.8, respectively. Colistin A and B were extracted from plasma using protein precipitation and from DSSD using an extraction basic solution. Both methods were validated, and the mean intra and inter-day accuracies and precisions were in accordance with FDA and EMA guidelines. Colistin in DPS was found to be stable for at least one week at room temperature (20-25°C). A statistically significant linear correlation was found between colistin extracted from plasma and from DPS [r(2) 0.9864 (P<0.0001, 95% CI 0.9699-0.9939) for colistin A and 0.9695 (P<0.0001, 95% CI 0.9310-0.9866) for colistin B, respectively]. DPS on DSSD represents a safe and cheap strategy to store and ship at room temperature plasma samples. Thus, it is suited for pharmacokinetic studies and therapeutic drug monitoring of colistin.
Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients' population. Nevertheless, therapeutic drug monitoring of colistin is still limited probably for the low number of laboratories which perform this analysis and for high shipment costs. We developed and validated new UHPLC-MS/MS methods to quantify colistin in plasma and in dried plasma spots (DPS) collected on dried sample spots devices (DSSD). Colistin A, Colistin B and polimixin B, used as internal standard, were detected using multiple reaction monitoring (MRM) of the following specific transitions: 585.5→534.9; 576, 578.5→527.9; 568.9 and 602.5→100.9, 551.9, 592.8, respectively. Colistin A and B were extracted from plasma using protein precipitation and from DSSD using an extraction basic solution. Both methods were validated, and the mean intra and inter-day accuracies and precisions were in accordance with FDA and EMA guidelines. Colistin in DPS was found to be stable for at least one week at room temperature (20-25°C). A statistically significant linear correlation was found between colistin extracted from plasma and from DPS [r(2) 0.9864 (P<0.0001, 95% CI 0.9699-0.9939) for colistin A and 0.9695 (P<0.0001, 95% CI 0.9310-0.9866) for colistin B, respectively]. DPS on DSSD represents a safe and cheap strategy to store and ship at room temperature plasma samples. Thus, it is suited for pharmacokinetic studies and therapeutic drug monitoring of colistin.Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients' population. Nevertheless, therapeutic drug monitoring of colistin is still limited probably for the low number of laboratories which perform this analysis and for high shipment costs. We developed and validated new UHPLC-MS/MS methods to quantify colistin in plasma and in dried plasma spots (DPS) collected on dried sample spots devices (DSSD). Colistin A, Colistin B and polimixin B, used as internal standard, were detected using multiple reaction monitoring (MRM) of the following specific transitions: 585.5→534.9; 576, 578.5→527.9; 568.9 and 602.5→100.9, 551.9, 592.8, respectively. Colistin A and B were extracted from plasma using protein precipitation and from DSSD using an extraction basic solution. Both methods were validated, and the mean intra and inter-day accuracies and precisions were in accordance with FDA and EMA guidelines. Colistin in DPS was found to be stable for at least one week at room temperature (20-25°C). A statistically significant linear correlation was found between colistin extracted from plasma and from DPS [r(2) 0.9864 (P<0.0001, 95% CI 0.9699-0.9939) for colistin A and 0.9695 (P<0.0001, 95% CI 0.9310-0.9866) for colistin B, respectively]. DPS on DSSD represents a safe and cheap strategy to store and ship at room temperature plasma samples. Thus, it is suited for pharmacokinetic studies and therapeutic drug monitoring of colistin.
Author D’Avolio, Antonio
Cangemi, Giuliana
Tripodi, Gino
Favata, Fabio
Barco, Sebastiano
Castagnola, Elio
Author_xml – sequence: 1
  givenname: Giuliana
  surname: Cangemi
  fullname: Cangemi, Giuliana
  organization: Clinical Pathology Laboratory Unit, Istituto Giannina Gaslini, Genoa, Italy
– sequence: 2
  givenname: Sebastiano
  surname: Barco
  fullname: Barco, Sebastiano
  organization: Clinical Pathology Laboratory Unit, Istituto Giannina Gaslini, Genoa, Italy
– sequence: 3
  givenname: Elio
  surname: Castagnola
  fullname: Castagnola, Elio
  organization: Infectious Disease Unit, Istituto Giannina Gaslini, Genoa, Italy
– sequence: 4
  givenname: Gino
  surname: Tripodi
  fullname: Tripodi, Gino
  organization: Clinical Pathology Laboratory Unit, Istituto Giannina Gaslini, Genoa, Italy
– sequence: 5
  givenname: Fabio
  surname: Favata
  fullname: Favata, Fabio
  organization: Department of Medical Sciences, University of Turin, Laboratory of Clinical Pharmacology and Pharmacogenetics, Amedeo di Savoia Hospital, Turin, Italy
– sequence: 6
  givenname: Antonio
  orcidid: 0000-0002-1321-4126
  surname: D’Avolio
  fullname: D’Avolio, Antonio
  email: antonio.davolio@unito.it
  organization: Department of Medical Sciences, University of Turin, Laboratory of Clinical Pharmacology and Pharmacogenetics, Amedeo di Savoia Hospital, Turin, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27505127$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1q3DAUhUVJaSZpX6CL4mU3dq5ky9JAN2X6k8KEFtJAd0KWrogG23IkzZTu-g59wz5JPTNJFl0ELtzL5Ttncc4ZORnDiIS8plBRoO3FptpMna7YfFcgKwD2jCyoFHXJ2ubHCVmAqGkpQPJTcpbSBgA4XTYvyCkTfD6ZWJCfH3CHfZgGHHOhR1vsdO-tzj6MRXDFzeW39erv7z9X1xdX18WA-TbYVLgQi3yLxd1Wj9k7bx55E3qfsh-LeaZep0EfTG30aB8eaQo5vSTPne4Tvrrf5-Tm08fvq8ty_fXzl9X7dWmaJculaBsHjkNraymlpQ40CIO87lprGiYF73SnaVtb2vKOd0ip4ctGgAAHTYP1OXl79J1iuNtiymrwyWDf6xHDNikqKa_bJQc2o2_u0W03oFVT9IOOv9RDWDPAjoCJIaWI7hGhoPaNqI3aN6L2jSiQCg6u8j-R8fmQV47a909L3x2lOAe08xhVMh5Hg9ZHNFnZ4J-S_wP8YKdq
CitedBy_id crossref_primary_10_3390_biomedicines11071962
crossref_primary_10_3390_antibiotics10040422
crossref_primary_10_1002_dta_2812
crossref_primary_10_1016_j_jchromb_2017_11_040
crossref_primary_10_2147_IDR_S209264
crossref_primary_10_1093_cid_cix757
crossref_primary_10_1093_cid_cix1047
crossref_primary_10_1093_cid_cix1048
crossref_primary_10_1016_j_chroma_2020_461731
crossref_primary_10_3999_jscpt_55_4_185
crossref_primary_10_1016_j_jchromb_2019_121842
crossref_primary_10_1016_j_jpba_2020_113201
crossref_primary_10_1016_j_jpha_2021_11_001
crossref_primary_10_1016_j_seh_2024_100058
crossref_primary_10_1016_j_jpba_2017_07_033
crossref_primary_10_1002_jssc_201901200
crossref_primary_10_3390_molecules27113489
crossref_primary_10_1097_FTD_0000000000000825
crossref_primary_10_1016_j_vascn_2024_107502
crossref_primary_10_3390_antibiotics12030437
crossref_primary_10_3390_biomedicines9101379
crossref_primary_10_1111_jvp_13022
crossref_primary_10_1002_jssc_202400583
crossref_primary_10_1097_FTD_0000000000000600
crossref_primary_10_4155_bio_2017_0269
crossref_primary_10_1016_j_jpba_2018_11_044
crossref_primary_10_36290_far_2022_006
crossref_primary_10_1097_FTD_0000000000000541
crossref_primary_10_1007_s00216_020_02873_5
crossref_primary_10_1016_j_heliyon_2023_e23111
crossref_primary_10_1016_j_jpba_2017_08_002
crossref_primary_10_1002_jssc_202100700
crossref_primary_10_1016_j_talanta_2020_121406
crossref_primary_10_1016_j_jchromb_2022_123131
crossref_primary_10_1016_j_ijantimicag_2021_106281
crossref_primary_10_1080_10826076_2020_1783291
crossref_primary_10_1080_10826076_2023_2262002
crossref_primary_10_1016_j_jpba_2019_03_023
crossref_primary_10_3390_ph17060753
Cites_doi 10.4155/bio.13.345
10.1016/S1473-3099(06)70580-1
10.1016/j.jpba.2010.02.026
10.1016/j.jchromb.2013.08.003
10.1016/S0140-6736(86)90837-8
10.1128/AAC.01367-09
10.1097/QCO.0b013e328332e672
10.1515/cclm-2014-0472
10.1016/S0378-4347(01)00326-7
10.1002/jssc.201000680
10.1592/phco.30.12.1279
10.1016/j.jpba.2013.08.022
10.1016/j.talanta.2013.07.043
10.1097/FTD.0b013e3182a8997c
10.1093/jac/dks285
10.1016/j.jpba.2008.12.016
10.1097/00007691-200010000-00014
10.1093/jac/dki461
10.1248/bpb.b15-00323
ContentType Journal Article
Copyright 2016 Elsevier B.V.
Copyright © 2016 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2016 Elsevier B.V.
– notice: Copyright © 2016 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jpba.2016.08.002
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-264X
EndPage 557
ExternalDocumentID 27505127
10_1016_j_jpba_2016_08_002
S0731708516304332
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
4.4
457
4G.
5GY
5VS
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AATCM
AAXUO
ABFRF
ABJNI
ABMAC
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADECG
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
M34
M36
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
RIG
RNS
ROL
RPZ
SCC
SCH
SDF
SDG
SDP
SES
SPC
SPCBC
SSK
SSP
SSZ
T5K
TEORI
YK3
~G-
29L
53G
AAQXK
AATTM
AAXKI
AAYWO
AAYXX
ABFNM
ABWVN
ABXDB
ACNNM
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AHHHB
AIGII
AIIUN
AJQLL
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
BNPGV
CITATION
FEDTE
FGOYB
G-2
HMT
HMU
HVGLF
HZ~
R2-
SCB
SEW
SPT
SSH
WUQ
XPP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ACLOT
EFKBS
~HD
ID FETCH-LOGICAL-c492t-764f0f506d3888d1f0a07ce53b6dc42875baba163d165b5be11c5947070f044e3
IEDL.DBID AIKHN
ISSN 0731-7085
1873-264X
IngestDate Sat Sep 27 21:13:44 EDT 2025
Thu Apr 03 07:02:30 EDT 2025
Tue Jul 01 01:17:45 EDT 2025
Thu Apr 24 23:06:06 EDT 2025
Fri Feb 23 02:25:41 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Therapeutic drug monitoring
UHPLC–MS/MS
Dried plasma spot
Colistin
Dried blood spots
LC–MS
Language English
License Copyright © 2016 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c492t-764f0f506d3888d1f0a07ce53b6dc42875baba163d165b5be11c5947070f044e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-1321-4126
PMID 27505127
PQID 1815369502
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1815369502
pubmed_primary_27505127
crossref_primary_10_1016_j_jpba_2016_08_002
crossref_citationtrail_10_1016_j_jpba_2016_08_002
elsevier_sciencedirect_doi_10_1016_j_jpba_2016_08_002
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-09-10
PublicationDateYYYYMMDD 2016-09-10
PublicationDate_xml – month: 09
  year: 2016
  text: 2016-09-10
  day: 10
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of pharmaceutical and biomedical analysis
PublicationTitleAlternate J Pharm Biomed Anal
PublicationYear 2016
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Tsai, Sun, Chen, Lin, Kuo (bib0090) 2013; 116
Ratjen, Rietschel, Kasel, Schwiertz, Starke, Beier, van Koningsbruggen, Grasemann (bib0065) 2006; 57
Li, Nation, Turnidge, Milne, Coulthard, Rayner, Paterson (bib0005) 2006; 6
Baietto, D’Avolio, Ariaudo, Corcione, Simiele, Cusato, Urbino, Di Perri, Ranieri, De Rosa (bib0045) 2013; 936
Li, Milne, Nation, Turnidge, Coulthard, Johnson (bib0060) 2001; 761
Passing, Bablok (bib0105) 1984; 22
John, Bennett, Blaser (bib0020) 2015
EMEA/CHMP/EWP/192217/2009: Guideline on bioanalytical method validation. The European Medicines Agency, 1 February (2011).
Dotsikas, Markopoulou, Koundourellis, Loukas (bib0080) 2011; 34
Baietto, Simiele, D’Avolio (bib0115) 2014; 6
Le Brun, de Graaf, Vinks (bib0055) 2000; 22
Gobin, Lemaître, Marchand, Couet, Olivier (bib0070) 2010; 54
Lim, Ly, Anderson, Yang, Macander, Jarkowski, Forrest, Bulitta, Tsuji (bib0015) 2010; 30
Baietto, D’Avolio, Marra, Simiele, Cusato, Pace, Ariaudo, De Rosa, Di Perri (bib0040) 2012; 67
Yamada, Ishiguro, Oku, Higuchi, Nakagawa, Noguchi, Yasuda, Fukumoto, Iwasaki, Akizawa, Furugen, Yamaguchi, Iseki (bib0025) 2015; 38
Baietto, D’Avolio, Pace, Simiele, Marra, Ariaudo, Di Perri, De Rosa (bib0050) 2014; 88
Baldelli, Cattaneo, Giodini, Baietto, Di Perri, D’Avolio, Clementi (bib0035) 2015; 53
Leporati, Bua, Mariano, Carignano, Stella, Biancone, Vincenti (bib0085) 2014; 36
Jansson, Karvanen, Cars, Plachouras, Friberg (bib0075) 2009; 49
Guidance for industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Rockville, May (2001).
Bland, Altman (bib0110) 1986; 1
Nation, Li (bib0010) 2009; 22
D’Avolio, Simiele, Siccardi, Baietto, Sciandra, Bonora, Di Perri (bib0030) 2010; 52
Baietto (10.1016/j.jpba.2016.08.002_bib0040) 2012; 67
10.1016/j.jpba.2016.08.002_bib0095
Li (10.1016/j.jpba.2016.08.002_bib0005) 2006; 6
Passing (10.1016/j.jpba.2016.08.002_bib0105) 1984; 22
Ratjen (10.1016/j.jpba.2016.08.002_bib0065) 2006; 57
Baietto (10.1016/j.jpba.2016.08.002_bib0115) 2014; 6
Dotsikas (10.1016/j.jpba.2016.08.002_bib0080) 2011; 34
Yamada (10.1016/j.jpba.2016.08.002_bib0025) 2015; 38
Leporati (10.1016/j.jpba.2016.08.002_bib0085) 2014; 36
Gobin (10.1016/j.jpba.2016.08.002_bib0070) 2010; 54
10.1016/j.jpba.2016.08.002_bib0100
Baldelli (10.1016/j.jpba.2016.08.002_bib0035) 2015; 53
Tsai (10.1016/j.jpba.2016.08.002_bib0090) 2013; 116
Bland (10.1016/j.jpba.2016.08.002_bib0110) 1986; 1
John (10.1016/j.jpba.2016.08.002_bib0020) 2015
Baietto (10.1016/j.jpba.2016.08.002_bib0050) 2014; 88
Li (10.1016/j.jpba.2016.08.002_bib0060) 2001; 761
Baietto (10.1016/j.jpba.2016.08.002_bib0045) 2013; 936
Lim (10.1016/j.jpba.2016.08.002_bib0015) 2010; 30
D’Avolio (10.1016/j.jpba.2016.08.002_bib0030) 2010; 52
Nation (10.1016/j.jpba.2016.08.002_bib0010) 2009; 22
Le Brun (10.1016/j.jpba.2016.08.002_bib0055) 2000; 22
Jansson (10.1016/j.jpba.2016.08.002_bib0075) 2009; 49
References_xml – volume: 22
  start-page: 535
  year: 2009
  ident: bib0010
  article-title: Colistin in the 21st century
  publication-title: Curr. Opin. Infect. Dis.
– volume: 53
  start-page: 435
  year: 2015
  end-page: 444
  ident: bib0035
  article-title: Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots
  publication-title: Clin. Chem. Lab. Med.
– volume: 54
  start-page: 941
  year: 2010
  end-page: 948
  ident: bib0070
  article-title: Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography–tandem mass spectrometry
  publication-title: Antimicrob. Agents Chemother.
– start-page: 549
  year: 2015
  end-page: 555
  ident: bib0020
  article-title: Polymyxins (polymyxin B and colistin)
  publication-title: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases
– volume: 49
  start-page: 760
  year: 2009
  end-page: 767
  ident: bib0075
  article-title: Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS
  publication-title: J. Pharm. Biomed. Anal.
– reference: EMEA/CHMP/EWP/192217/2009: Guideline on bioanalytical method validation. The European Medicines Agency, 1 February (2011).
– volume: 936
  start-page: 42
  year: 2013
  end-page: 47
  ident: bib0045
  article-title: Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots
  publication-title: J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.
– volume: 30
  start-page: 1279
  year: 2010
  end-page: 1291
  ident: bib0015
  article-title: Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing
  publication-title: Pharmacother. J. Hum. Pharmacol. Drug Ther.
– volume: 6
  start-page: 425
  year: 2014
  end-page: 427
  ident: bib0115
  article-title: How effective is [corrected] the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring?
  publication-title: Bioanalysis
– volume: 38
  start-page: 1430
  year: 2015
  end-page: 1433
  ident: bib0025
  article-title: Successful colistin treatment of multidrug-resistant Pseudomonas aeruginosa infection using a rapid method for determination of colistin in plasma: usefulness of therapeutic drug monitoring
  publication-title: Biol. Pharm. Bull.
– volume: 761
  start-page: 167
  year: 2001
  end-page: 175
  ident: bib0060
  article-title: A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography
  publication-title: J. Chromatogr. B: Biomed. Sci. Appl.
– volume: 22
  start-page: 431
  year: 1984
  end-page: 445
  ident: bib0105
  article-title: Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in clinical chemistry, part II
  publication-title: J. Clin. Chem. Clin. Biochem.
– volume: 36
  start-page: 182
  year: 2014
  end-page: 191
  ident: bib0085
  article-title: Determination by LC–MS/MS of colistins A and B in plasma and ultrafiltrate from critically ill patients undergoing continuous venovenous hemodiafiltration
  publication-title: Ther. Drug Monit.
– volume: 88
  start-page: 66
  year: 2014
  end-page: 70
  ident: bib0050
  article-title: Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots
  publication-title: J. Pharm. Biomed. Anal.
– volume: 1
  start-page: 307
  year: 1986
  end-page: 310
  ident: bib0110
  article-title: Statistical methods for assessing agreement between two methods of clinical measurement
  publication-title: Lancet
– volume: 22
  start-page: 589
  year: 2000
  end-page: 593
  ident: bib0055
  article-title: High-performance liquid chromatographic method for the determination of colistin in serum
  publication-title: Ther. Drug Monit.
– reference: Guidance for industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Rockville, May (2001).
– volume: 52
  start-page: 774
  year: 2010
  end-page: 780
  ident: bib0030
  article-title: HPLC–MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions
  publication-title: J. Pharm. Biomed. Anal.
– volume: 57
  start-page: 306
  year: 2006
  end-page: 311
  ident: bib0065
  article-title: Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
  publication-title: J. Antimicrob. Chemother.
– volume: 34
  start-page: 37
  year: 2011
  end-page: 45
  ident: bib0080
  article-title: Validation of a novel LC–MS/MS method for the quantitation of colistin A and B in human plasma
  publication-title: J. Sep. Sci.
– volume: 6
  start-page: 589
  year: 2006
  end-page: 601
  ident: bib0005
  article-title: Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections
  publication-title: Lancet Infect. Dis.
– volume: 67
  start-page: 2645
  year: 2012
  end-page: 2649
  ident: bib0040
  article-title: Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC–MS
  publication-title: J. Antimicrob. Chemother.
– volume: 116
  start-page: 593
  year: 2013
  end-page: 603
  ident: bib0090
  article-title: Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography–tandem mass spectrometry
  publication-title: Talanta
– volume: 6
  start-page: 425
  year: 2014
  ident: 10.1016/j.jpba.2016.08.002_bib0115
  article-title: How effective is [corrected] the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring?
  publication-title: Bioanalysis
  doi: 10.4155/bio.13.345
– start-page: 549
  year: 2015
  ident: 10.1016/j.jpba.2016.08.002_bib0020
  article-title: Polymyxins (polymyxin B and colistin)
– volume: 6
  start-page: 589
  year: 2006
  ident: 10.1016/j.jpba.2016.08.002_bib0005
  article-title: Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(06)70580-1
– volume: 52
  start-page: 774
  year: 2010
  ident: 10.1016/j.jpba.2016.08.002_bib0030
  article-title: HPLC–MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2010.02.026
– volume: 936
  start-page: 42
  year: 2013
  ident: 10.1016/j.jpba.2016.08.002_bib0045
  article-title: Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots
  publication-title: J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.
  doi: 10.1016/j.jchromb.2013.08.003
– volume: 1
  start-page: 307
  year: 1986
  ident: 10.1016/j.jpba.2016.08.002_bib0110
  article-title: Statistical methods for assessing agreement between two methods of clinical measurement
  publication-title: Lancet
  doi: 10.1016/S0140-6736(86)90837-8
– volume: 54
  start-page: 941
  year: 2010
  ident: 10.1016/j.jpba.2016.08.002_bib0070
  article-title: Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography–tandem mass spectrometry
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01367-09
– ident: 10.1016/j.jpba.2016.08.002_bib0100
– volume: 22
  start-page: 535
  year: 2009
  ident: 10.1016/j.jpba.2016.08.002_bib0010
  article-title: Colistin in the 21st century
  publication-title: Curr. Opin. Infect. Dis.
  doi: 10.1097/QCO.0b013e328332e672
– volume: 53
  start-page: 435
  year: 2015
  ident: 10.1016/j.jpba.2016.08.002_bib0035
  article-title: Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots
  publication-title: Clin. Chem. Lab. Med.
  doi: 10.1515/cclm-2014-0472
– volume: 761
  start-page: 167
  year: 2001
  ident: 10.1016/j.jpba.2016.08.002_bib0060
  article-title: A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography
  publication-title: J. Chromatogr. B: Biomed. Sci. Appl.
  doi: 10.1016/S0378-4347(01)00326-7
– volume: 34
  start-page: 37
  year: 2011
  ident: 10.1016/j.jpba.2016.08.002_bib0080
  article-title: Validation of a novel LC–MS/MS method for the quantitation of colistin A and B in human plasma
  publication-title: J. Sep. Sci.
  doi: 10.1002/jssc.201000680
– volume: 30
  start-page: 1279
  year: 2010
  ident: 10.1016/j.jpba.2016.08.002_bib0015
  article-title: Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing
  publication-title: Pharmacother. J. Hum. Pharmacol. Drug Ther.
  doi: 10.1592/phco.30.12.1279
– volume: 88
  start-page: 66
  year: 2014
  ident: 10.1016/j.jpba.2016.08.002_bib0050
  article-title: Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2013.08.022
– volume: 116
  start-page: 593
  year: 2013
  ident: 10.1016/j.jpba.2016.08.002_bib0090
  article-title: Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography–tandem mass spectrometry
  publication-title: Talanta
  doi: 10.1016/j.talanta.2013.07.043
– volume: 36
  start-page: 182
  year: 2014
  ident: 10.1016/j.jpba.2016.08.002_bib0085
  article-title: Determination by LC–MS/MS of colistins A and B in plasma and ultrafiltrate from critically ill patients undergoing continuous venovenous hemodiafiltration
  publication-title: Ther. Drug Monit.
  doi: 10.1097/FTD.0b013e3182a8997c
– volume: 67
  start-page: 2645
  year: 2012
  ident: 10.1016/j.jpba.2016.08.002_bib0040
  article-title: Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC–MS
  publication-title: J. Antimicrob. Chemother.
  doi: 10.1093/jac/dks285
– volume: 49
  start-page: 760
  year: 2009
  ident: 10.1016/j.jpba.2016.08.002_bib0075
  article-title: Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2008.12.016
– volume: 22
  start-page: 431
  year: 1984
  ident: 10.1016/j.jpba.2016.08.002_bib0105
  article-title: Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in clinical chemistry, part II
  publication-title: J. Clin. Chem. Clin. Biochem.
– volume: 22
  start-page: 589
  year: 2000
  ident: 10.1016/j.jpba.2016.08.002_bib0055
  article-title: High-performance liquid chromatographic method for the determination of colistin in serum
  publication-title: Ther. Drug Monit.
  doi: 10.1097/00007691-200010000-00014
– volume: 57
  start-page: 306
  year: 2006
  ident: 10.1016/j.jpba.2016.08.002_bib0065
  article-title: Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
  publication-title: J. Antimicrob. Chemother.
  doi: 10.1093/jac/dki461
– ident: 10.1016/j.jpba.2016.08.002_bib0095
– volume: 38
  start-page: 1430
  year: 2015
  ident: 10.1016/j.jpba.2016.08.002_bib0025
  article-title: Successful colistin treatment of multidrug-resistant Pseudomonas aeruginosa infection using a rapid method for determination of colistin in plasma: usefulness of therapeutic drug monitoring
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.b15-00323
SSID ssj0005194
Score 2.350446
Snippet [Display omitted] •A new method to quantify colistin A and B in dried plasma spots (DPS) is reported.•The method was compared to a standard method to quantify...
Quantification of colistin in plasma samples may be very useful in optimizing therapy especially in special patients' population. Nevertheless, therapeutic...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 551
SubjectTerms Anti-Bacterial Agents - blood
Anti-Bacterial Agents - chemistry
Calibration
Chromatography, High Pressure Liquid - methods
Colistin
Colistin - blood
Colistin - chemistry
Dried Blood Spot Testing - methods
Dried blood spots
Dried plasma spot
Drug Monitoring - methods
Humans
LC–MS
Limit of Detection
Plasma - chemistry
Reproducibility of Results
Tandem Mass Spectrometry - methods
Therapeutic drug monitoring
UHPLC–MS/MS
Title Development and validation of UHPLC–MS/MS methods for the quantification of colistin in plasma and dried plasma spots
URI https://dx.doi.org/10.1016/j.jpba.2016.08.002
https://www.ncbi.nlm.nih.gov/pubmed/27505127
https://www.proquest.com/docview/1815369502
Volume 129
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Pa9swFBdteumldFvXrtuCBqWX1YkUS3JyLGHB25oQSAO5Cf0zJLROtjiMXsa-w77hPsmeLDtZD-1h4IvNe7LQe376PfzTewhduJjp8jSOIUJFzHVtpI3REWDTHlFUKW5Llu9IpFP2ZcZne6hfn4XxtMoq9oeYXkbr6km7Ws32aj5vT8A5aeIRg4jLKlz76KADu323gQ6uP39NRzumBy37IXr5yCtUZ2cCzWux0r78EBWtwKp8an96Cn-W-9DgGB1VABJfhzm-QHsuf4kux6EC9cMVvt0dqFpf4Us83tWmfniFfvxDEsIqtxgcbR7aKuFlhqfp-Kb_59fv4aQ9nODQXXqNAddiwIn420YFatFWHob1MSLHcK0Ah9-rclAL-betH0DeXKxP0HTw6bafRlXvhciwXqeIEsEyknEibAw5sqUZUSQxjsdaWOPTLK6VVrD0lgquuXaUGt5jCUSQjDDm4teokS9zd4Ywg9huuomxAOWYzTpaM8eUySDzswnE4jeI1isuTVWY3PfHuJM1A20hvZWkt5L0TTMJ6Hzc6qxCWY5npXltSPnIuSTsG8_qfaitLuGr879SVO6Wm7UEXMRj0eNe5jS4w3YevmI-wKjk_D_f-hYd-jtPSqHkHWoU3zfuPSCfQjfRfusnbVb-_RfWFQOk
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NThsxELZoemgvCPoLlNaVKi5lic3aXnJEUVHaJihSEomb5b-VgsomkEQoF8Q78IZ9EmbWu4Ee4FBpT97xruWZHX-j_WaGkG8hFbbMxnFMmUSEI59Y52wC2LTFDDdG-pLle6o6I_HrTJ6tkXadC4O0ysr3R59eeutqpFntZnM6HjcHYJw8Q8Sg0rIK1wvyUmCbAzDqg5tHPA9edkNE6QTFq8yZSPI6n1osPsTVQeRUPnU6PYU-y1PoZIOsV_CRHscVbpK1ULwhe_1Yf3q5T4cP6VSzfbpH-w-VqZdvyfUjihA1hadgZuPYVIlOcjrq9Lvtv7d3vUGzN6Cxt_SMAqqlgBLp5cJEYtFKHh6LHqKgcE0BhV-Y8qEeom9fD0DUPJ-9I6OTH8N2J6k6LyROtA7nSaZEznLJlE8hQvY8Z4ZlLsjUKu8wyJLWWAMb77mSVtrAuZMtkYH_yJkQIX1PGsWkCB8JFeDZ3VHmPAA54fNDa0UQxuUQ9_kMPPEW4fWOa1eVJcfuGH90zT8716gljVrS2DKTwZzvqznTWJTjWWlZK1L_Y1oaTo1n532tta7hm8MfKaYIk8VMAyqSqWpJlPkQzWG1DqyXDyAq2_7Pt34hrzrDXld3f57-3iGv8Q7SUzj7RBrzq0XYBQw0t59LG78H8MoEZg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+and+validation+of+UHPLC-MS%2FMS+methods+for+the+quantification+of+colistin+in+plasma+and+dried+plasma+spots&rft.jtitle=Journal+of+pharmaceutical+and+biomedical+analysis&rft.au=Cangemi%2C+Giuliana&rft.au=Barco%2C+Sebastiano&rft.au=Castagnola%2C+Elio&rft.au=Tripodi%2C+Gino&rft.date=2016-09-10&rft.issn=1873-264X&rft.eissn=1873-264X&rft.volume=129&rft.spage=551&rft_id=info:doi/10.1016%2Fj.jpba.2016.08.002&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0731-7085&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0731-7085&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0731-7085&client=summon